Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tears Again Sensitive
- Development stage
- Unknown
- Lead developer
- Optima Pharmazeutische
- Modality
- Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Tears Again Sensitive is an ophthalmic product designed to relieve symptoms of dry eyes, such as burning, irritation, discomfort, itching, and foreign body sensation. It is available as an eye spray for application on closed eyelids and is formulated to be gentle for sensitive eyes. The product stabilizes the protective lipid layer of the tear film and minimizes evaporation of tear fluid, thereby improving ocular surface hydration[3][6][9]. Unlike traditional eye drops that are applied directly into the eye, this spray can be used with contact lenses in place and does not require direct contact with the eyeball. It is preservative-free and suitable for frequent use.
- Brand names
- Tears Again Sensitive
- Other names
- TEARS Again Sensitive Eye SprayTEARS AGAIN® Eye Spray (related but not identical)TEARS AGAIN® Hyaluron Eye Drops (related but not identical)
Beyond the preview
Go deeper on Tears Again Sensitive.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tears Again Sensitive.